Global Information
회사소개 | 문의 | 위시리스트

D형 간염 : 역학 예측(2027년)

Hepatitis D - Epidemiology Forecast to 2028

리서치사 DelveInsight Business Research LLP
발행일 2019년 01월 상품 코드 534883
페이지 정보 영문 50 Pages
가격
US $ 3,250 ₩ 3,885,000 PDF by E-mail (Single User License)
US $ 6,500 ₩ 7,770,000 PDF by E-mail (Site License)
US $ 9,750 ₩ 11,655,000 PDF by E-mail (Global License)


D형 간염 : 역학 예측(2027년) Hepatitis D - Epidemiology Forecast to 2028
발행일 : 2019년 01월 페이지 정보 : 영문 50 Pages

주요 8개국의 D형 간염 총유병수는 2016년에 1,054만 6,938명으로 추산되었습니다.

D형 간염에 대해 조사했으며, 질병 개요, 환자 배경, 주요 8개국(미국, 영국, 독일, 프랑스, 이탈리아, 스페인, 일본, 중국)의 유병수 동향, 향후 10년간 역학적 예측, 성장요인 및 시장 장벽, 향후 시장 기회 등을 정리하여 전해드립니다.

목차

제1장 주요 인사이트

제2장 질병 배경과 개요 : D형 간염

  • 서론
  • 분류
  • 질병의 진행에 영향을 미치는 요인
  • 병인
  • 증상
  • 발증기서
  • 병태생리
  • 진단
  • 예방

제3장 역학과 환자 인구

  • 주요 소견
  • 주요 8개국의 D형 간염 유병수

제4장 D형 간염의 역학 : 국가별

  • 미국
    • D형 간염 유병수
    • D형 간염 유병수 : 중증도별
    • D형 간염 유병수 : 성별
    • D형 간염 유병수 : 연령별
    • D형 간염 이환수
  • EU 5개국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 영국
  • 일본
  • 중국

제5장 부록

제6장 조사 방법

제7장 DelveInsight의 서비스 내용

제8장 면책사항

제9장 DelveInsight 소개

KSA 18.04.27

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 1: 8MM, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 2: The United States, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 3: The United States, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 4: The United States, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Table 5: The United States, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 6: The United States, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 7: EU5, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 8: France, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 9: France, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 10: France, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 11: France, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 12: France, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 13: Germany, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 14: Germany, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 15: Germany, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Table 16: Germany, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 17: Germany, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 18: Italy, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 19: Italy, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 20: Italy, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Table 21: Italy, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 22: Italy, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 23: Spain, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 24: Spain, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 25: Spain, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 26: Spain, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 27: Spain, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 28: The United Kingdom, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 29: The United Kingdom, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 30: The United Kingdom, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 31: The United Kingdom, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 32: The United Kingdom, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 33: Japan, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 34: Japan, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 35: Japan, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 36: Japan, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 37: Japan, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 38: China, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 39: China, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 40: China, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 41: China, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 42: China, Diagnosed cases of Hepatitis D, 2016-2028

List of Figures

  • Figure 1: Hepatitis Delta Virus Structure
  • Figure 2: Pathogenesis of Hepatitis D
  • Figure 3: Diagnostic markers in various hepatitis D disease patterns
  • Figure 4: 8MM, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 5: The United States, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 6: The United States, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 7: The United States, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 8: The United States, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 9: The United States, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 10: EU5, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 11: France, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 12: France, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 13: France, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 14: France, Age-specific Hepatitis D Prevalence, 2016-2028
  • Figure 15: France, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 16: Germany, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 17: Germany, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 18: Germany, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 19: Germany, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 20: Germany, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 21: Italy, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 22: Italy, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 23: Italy, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 24: Italy, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 25: Italy, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 26: Spain, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 27: Spain, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 28: Spain, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 29: Spain, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 30: Spain, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 31: The United Kingdom, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 32: The United Kingdom, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 33: The United Kingdom, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 34: The United Kingdom, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 35: The United Kingdom, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 36: Japan, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 37: Japan, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 38: Japan, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 39: Japan, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 40: Japan, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 41: China, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 42: China, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 43: China, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 44: China, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 45: China, Diagnosed cases of Hepatitis D, 2016-2028

DelveInsight's 'Hepatitis D - Epidemiology Forecast to 2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Hepatitis D in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan
  • China

Study Period: 2016-2028

Hepatitis D Epidemiology

The Hepatitis D epidemiology division provide the insights about historical and current patient pool and forecasted trend for each of the 8 major countries. The epidemiology data for Hepatitis D are studied through all possible division to give a better understanding about the Disease scenario in 8MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Hepatitis D Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalence by Severity (Fulminant, Acute & Chronic), Gender Specific prevalence, Age Specific prevalence and diagnosed cases] of Hepatitis D in the 8MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom), Japan and China from 2016-2028.

The DelveInsight report also provides the epidemiology trends observed in the 8MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, total prevalent population of Hepatitis D in 8 major markets was estimated to be 10,546,938 in 2016.

Report Scope

  • The report covers detailed overview of Hepatitis D explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Hepatitis D in 8 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan and China.
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 8MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D

Key strengths

  • 10 Year Forecast of Hepatitis D epidemiology
  • 8MM Coverage
  • Diagnosed Prevalent cases of Hepatitis D
  • Prevalent Cases according to segmentation: by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D in 8MM

Key assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Disease Background and Overview: Hepatitis D

  • 2.1. Introduction
  • 2.2. Classification
  • 2.3. Factors influencing Hepatitis D Progression
  • 2.4. Disease Causes
  • 2.5. HDV-Symptoms
  • 2.6. Pathogenesis
  • 2.7. Pathophysiology
  • 2.8. HDV Diagnosis
  • 2.9. Prevention

3. Epidemiology and Patient Population

  • 3.1. Key Findings
  • 3.2. 8MM Prevalent Population of Hepatitis D

4. Country Wise-Epidemiology of Hepatitis D

  • 4.1. United States
    • 4.1.1. Prevalent cases of Hepatitis D in the United States
    • 4.1.2. Prevalent Population of Hepatitis D by severity
    • 4.1.3. Gender Specific Hepatitis D Prevalence
    • 4.1.4. Age Specific Hepatitis D Prevalence
    • 4.1.5. Diagnosed cases of Chronic Hepatitis D
  • 4.2. EU5
    • 4.2.1. Prevalent Population of Hepatitis D in EU5
  • 4.3. France
    • 4.3.1. Prevalent Population of Hepatitis D
    • 4.3.2. Prevalent Population of Hepatitis D by severity
    • 4.3.3. Gender Specific Hepatitis D Prevalence
    • 4.3.4. Age Specific Hepatitis D Prevalence
    • 4.3.5. Diagnosed cases of Chronic Hepatitis D
  • 4.4. Germany
    • 4.4.1. Prevalent Population of Hepatitis D
    • 4.4.2. Prevalent Population of Hepatitis D by severity
    • 4.4.3. Gender Specific Hepatitis D Prevalence
    • 4.4.4. Age Specific Hepatitis D Prevalence
    • 4.4.5. Diagnosed cases of Chronic Hepatitis D
  • 4.5. Italy
    • 4.5.1. Prevalent Population of Hepatitis D
    • 4.5.2. Prevalent Population of Hepatitis D by severity
    • 4.5.3. Gender Specific Hepatitis D Prevalence
    • 4.5.4. Age Specific Hepatitis D Prevalence
    • 4.5.5. Diagnosed cases of Chronic Hepatitis D
  • 4.6. Spain
    • 4.6.1. Prevalent Population of Hepatitis D
    • 4.6.2. Prevalent Population of Hepatitis D by severity
    • 4.6.3. Gender Specific Hepatitis D Prevalence
    • 4.6.4. Age Specific Hepatitis D Prevalence
    • 4.6.5. Diagnosed cases of Chronic Hepatitis D
  • 4.7. United Kingdom
    • 4.7.1. Prevalent Population of Hepatitis D
    • 4.7.2. Prevalent Population of Hepatitis D by severity
    • 4.7.3. Gender Specific Hepatitis D Prevalence
    • 4.7.4. Age Specific Hepatitis D Prevalence
    • 4.7.5. Diagnosed cases of Chronic Hepatitis D
  • 4.8. Japan
    • 4.8.1. Prevalent Population of Hepatitis D
    • 4.8.2. Prevalent Population of Hepatitis D by severity
    • 4.8.3. Gender Specific Hepatitis D Prevalence
    • 4.8.4. Age Specific Hepatitis D Prevalence
    • 4.8.5. Diagnosed cases of Chronic Hepatitis D
  • 4.9. China
    • 4.9.1. Prevalent Population of Hepatitis D
    • 4.9.2. Prevalent Population of Hepatitis D by severity
    • 4.9.3. Gender Specific Hepatitis D Prevalence
    • 4.9.4. Age Specific Hepatitis D Prevalence
    • 4.9.5. Diagnosed cases of Chronic Hepatitis D

5. Appendix

6. Report Methodology

  • 6.1. Sources Used

7. DelveInsight Capabilities

8. Disclaimer

9. About DelveInsight

Back to Top
전화 문의
F A Q